Form 4: Natera Executive Solomon Moshkevich Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,647 shares of common stock on May 28, 2024, to cover tax obligations related to vesting RSUs.
Summary
- On May 28, 2024, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,647 shares of the company's common stock.
- The shares were sold at a price of $109.9595 per share.
- The sale was executed to satisfy tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
- The transaction was conducted under a pre-arranged trading plan (Rule 10b5-1(c)) established on June 10, 2022.
- Following the transaction, Moshkevich directly owns 114,186 shares of Natera, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and are generally viewed as routine transactions.
Key Dates
| Date | Description |
|---|---|
| 06/10/2022 | Date of Stock Unit Agreement grant. |
| 05/28/2024 | Date of the transaction (stock sale). |
| 05/30/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.